Acetylsalicylic acid interferes with embryonic kidney growth and development by a prostaglandin-independent mechanism

S. Welham, A. Sparrow, D. Gardner, M. Elmes
{"title":"Acetylsalicylic acid interferes with embryonic kidney growth and development by a prostaglandin-independent mechanism","authors":"S. Welham, A. Sparrow, D. Gardner, M. Elmes","doi":"10.5527/wjn.v6.i1.21","DOIUrl":null,"url":null,"abstract":"AIM To evaluate the effects of the non-selective, non-steroidal anti-inflammatory drug (NSAID) acetylsalicylic acid (ASA), on ex vivo embryonic kidney growth and development. METHODS Pairs of fetal mouse kidneys at embryonic day 12.5 were cultured ex vivo in increasing concentrations of ASA (0.04-0.4 mg/mL) for up to 7 d. One organ from each pair was grown in control media and was used as the internal control for the experimental contralateral organ. In some experiments, organs were treated with ASA for 48 h and then transferred either to control media alone or control media containing 10 μmol/L prostaglandin E2 (PGE2) for a further 5 d. Fetal kidneys were additionally obtained from prostaglandin synthase 2 homozygous null or heterozygous (PTGS2-/- and PTGS2-/+) embryos and grown in culture. Kidney cross-sectional area was used to determine treatment effects on kidney growth. Whole-mount labelling to fluorescently detect laminin enabled crude determination of epithelial branching using confocal microscopy. RESULTS Increasing ASA concentration (0.1, 0.2 and 0.4 mg/mL) significantly inhibited metanephric growth (P < 0.05). After 7 d of culture, exposure to 0.2 mg/mL and 0.4 mg/mL reduced organ size to 53% and 23% of control organ size respectively (P < 0.01). Addition of 10 μmol/L PGE2 to culture media after exposure to 0.2 mg/mL ASA for 48 h resulted in a return of growth area to control levels. Application of control media alone after cessation of ASA exposure showed no benefit on kidney growth. Despite the apparent recovery of growth area with 10 μmol/L PGE2, no obvious renal tubular structures were formed. The number of epithelial tips generated after 48 h exposure to ASA was reduced by 40% (0.2 mg/mL; P < 0.05) and 47% (0.4 mg/mL; P < 0.01). Finally, growth of PTGS2-/- and PTGS2+/- kidneys in organ culture showed no differences, indicating that PTGS2 derived PGE2 may at best have a minor role. CONCLUSION ASA reduces early renal growth and development but the role of prostaglandins in this may be minor.","PeriodicalId":23745,"journal":{"name":"World Journal of Nephrology","volume":"32 1","pages":"21 - 28"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5527/wjn.v6.i1.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

AIM To evaluate the effects of the non-selective, non-steroidal anti-inflammatory drug (NSAID) acetylsalicylic acid (ASA), on ex vivo embryonic kidney growth and development. METHODS Pairs of fetal mouse kidneys at embryonic day 12.5 were cultured ex vivo in increasing concentrations of ASA (0.04-0.4 mg/mL) for up to 7 d. One organ from each pair was grown in control media and was used as the internal control for the experimental contralateral organ. In some experiments, organs were treated with ASA for 48 h and then transferred either to control media alone or control media containing 10 μmol/L prostaglandin E2 (PGE2) for a further 5 d. Fetal kidneys were additionally obtained from prostaglandin synthase 2 homozygous null or heterozygous (PTGS2-/- and PTGS2-/+) embryos and grown in culture. Kidney cross-sectional area was used to determine treatment effects on kidney growth. Whole-mount labelling to fluorescently detect laminin enabled crude determination of epithelial branching using confocal microscopy. RESULTS Increasing ASA concentration (0.1, 0.2 and 0.4 mg/mL) significantly inhibited metanephric growth (P < 0.05). After 7 d of culture, exposure to 0.2 mg/mL and 0.4 mg/mL reduced organ size to 53% and 23% of control organ size respectively (P < 0.01). Addition of 10 μmol/L PGE2 to culture media after exposure to 0.2 mg/mL ASA for 48 h resulted in a return of growth area to control levels. Application of control media alone after cessation of ASA exposure showed no benefit on kidney growth. Despite the apparent recovery of growth area with 10 μmol/L PGE2, no obvious renal tubular structures were formed. The number of epithelial tips generated after 48 h exposure to ASA was reduced by 40% (0.2 mg/mL; P < 0.05) and 47% (0.4 mg/mL; P < 0.01). Finally, growth of PTGS2-/- and PTGS2+/- kidneys in organ culture showed no differences, indicating that PTGS2 derived PGE2 may at best have a minor role. CONCLUSION ASA reduces early renal growth and development but the role of prostaglandins in this may be minor.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乙酰水杨酸通过不依赖前列腺素的机制干扰胚胎肾脏的生长和发育
目的探讨非选择性非甾体抗炎药乙酰水杨酸(ASA)对体外胚胎肾脏生长发育的影响。方法将胚胎期12.5天的一对胎鼠肾脏在增加ASA浓度(0.04-0.4 mg/mL)的条件下体外培养7 d。每对肾脏中有一个器官在对照培养基中培养,作为实验对侧器官的内对照。在一些实验中,器官用ASA处理48 h,然后转移到单独的对照培养基或含有10 μmol/L前列腺素E2 (PGE2)的对照培养基中再培养5 d。在前列腺素合成酶2纯合或杂合(PTGS2-/-和PTGS2-/+)胚胎中获得胎儿肾脏,并进行培养。肾脏横截面积测定治疗对肾脏生长的影响。全贴装标记荧光检测层粘连蛋白使使用共聚焦显微镜的上皮分支粗测定。结果增加ASA浓度(0.1、0.2、0.4 mg/mL)显著抑制后肾细胞生长(P < 0.05)。培养7 d后,暴露于0.2 mg/mL和0.4 mg/mL中,器官大小分别减少到对照组的53%和23% (P < 0.01)。在0.2 mg/mL ASA作用48 h后,在培养基中添加10 μmol/L PGE2,生长面积恢复到对照水平。停止ASA暴露后单独应用对照培养基对肾脏生长没有益处。10 μmol/L PGE2虽能明显恢复生长面积,但未形成明显肾小管结构。暴露于ASA 48 h后产生的上皮尖数量减少了40% (0.2 mg/mL;P < 0.05), 47% (0.4 mg/mL;P < 0.01)。最后,在器官培养中,PTGS2-/-和PTGS2+/-肾脏的生长没有差异,这表明PTGS2衍生的PGE2最多只能起到次要作用。结论ASA降低早期肾脏生长发育,但前列腺素在其中的作用可能较小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study Seeing through the myths: Practical aspects of diagnostic point-of-care ultrasound in nephrology Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis Cryptococcosis in kidney transplant recipients: Current understanding and practices
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1